Stock warrant tracker
Every outstanding warrant series recorded in a Signal8 dilution snapshot, one row per series: the shares it can be exercised into, the exercise price (strike), the expiry date, whether the price can reset after a later financing, and the SEC filing each figure was read from. Exercise prices and share counts are restated for every stock split since the filing, so they compare directly with the current share price.
5,328 warrant series at 1,056 companies. 777 in the money, 58 expiring in the next 30 days, 39 waiting on a stockholder vote or other stated condition, 0 becoming exercisable in the next 30 days.
Outstanding warrants
| Series | Shares | Exercise price | Last price | Vs strike | Expiry | Exercisable | Terms | Overhang | Source | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series F Common Warrants (May 2025 public offering) | $4.15 | $6.1M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| August 2026 Inducement Warrants ($0.60) | $0.3011 | $6.1M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| Extended Legacy Warrants ($40.00, exp. Dec 31, 2026) | $0.3011 | $6.1M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| March 2026 Consultant Warrants ($4.00) | $0.3011 | $6.1M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| March 2026 Consultant Warrants ($5.00) | $0.3011 | $6.1M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| Regulation A Unit Warrants ($4.50) | $0.3011 | $6.1M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| September 2024 PIPE Warrants ($4.00, exp. 2029) | $0.3011 | $6.1M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| June 2023 Placement Agent Warrants (equity-classified 'Common stock warrants') | $0.2868 | $6.0M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Nant Capital common warrants (October 2026 private placement) | $0.2868 | $6.0M | 8-K, Nov 3, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Nant Capital pre-funded warrants (October 2026 private placement) | $0.2868 | $6.0M | 8-K, Nov 3, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| November 2024 placement agent warrants (labelled 'Series C warrants issued' at $1.625) | $0.2868 | $6.0M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Purchase Warrants issued - June 2023 (liability-classified) | $0.2868 | $6.0M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Purchase Warrants issued - November 2022 (liability-classified) | $0.2868 | $6.0M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Representative (underwriter) warrants - February 2024 | $0.2868 | $6.0M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| September 2025 placement agent warrants (labelled 'Series E warrants issued' at $1.475) | $0.2868 | $6.0M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series A warrants (February 2024 public offering) | $0.2868 | $6.0M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series D warrants (November 2024 inducement) | $0.2868 | $6.0M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series E warrants (September 2025 inducement) | $0.2868 | $6.0M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| April 2026 Pre-Funded Warrants | $0.9900 | $6.0M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| January 2025 Placement Agent Warrants (H.C. Wainwright) | $0.9900 | $6.0M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| July 2022 Placement Agent Warrants | $0.9900 | $6.0M | S-1, May 4, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| June 2025 Placement Agent Warrants (H.C. Wainwright) | $0.9900 | $6.0M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Legacy warrants not itemised (pre-2025 residual) | $0.9900 | $6.0M | 10-K, Mar 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| March 2025 Placement Agent Warrants (H.C. Wainwright) | $0.9900 | $6.0M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Series A Warrants issued to affiliates (July 2022) | $0.9900 | $6.0M | S-1, May 4, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Series E Warrants (January 2025 private placement) | $0.9900 | $6.0M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Series F Warrants (March 2025 private placement) | $0.9900 | $6.0M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Series G-1 Warrants (June 2025 inducement) | $0.9900 | $6.0M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Series G-2 Warrants (June 2025 inducement) | $0.9900 | $6.0M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Series H Warrants (April 2026 private placement) | $0.9900 | $6.0M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Warrants at $165.00 exercise price (10-Q warrant table) | $2.01 | $6.0M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| Warrants at $320.10 exercise price (10-Q warrant table) | $2.01 | $6.0M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| Public warrants (NASDAQ: OXBRW), $7.50, expiring March 26, 2029 | $0.7204 | $5.9M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Series A Ordinary Share Purchase Warrants (Feb 2025 private placement), $4.25, expiring Feb 24, 2027 | $0.7204 | $5.9M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Series B Ordinary Share Purchase Warrants (Feb 2025 private placement), $4.25, expiring May 8, 2030 | $0.7204 | $5.9M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| January 2023 pre-funded warrants | $0.4324 | $5.9M | 6-K EX-99.1, Sep 18, 2026Dilution tabAs of Oct 29, 2026 | ||||||||
| January 2023 public offering warrants (Aegis underwritten offering) | $0.4324 | $5.9M | 6-K EX-99.1, Sep 18, 2026Dilution tabAs of Oct 29, 2026 | ||||||||
| New Warrants (December 2024 warrant inducement) | $0.4324 | $5.9M | 20-F, Jan 30, 2026Dilution tabAs of Oct 29, 2026 | ||||||||
| Advisory Warrants – Arca, immediately exercisable tranche | $3.92 | $5.9M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| May 2026 Placement Agent Pre-Funded Warrants (Lucid) | $3.92 | $5.9M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| May 2026 Pre-Funded Warrants – LHE LNG, exercisable portion | $3.92 | $5.9M | 3, Oct 8, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| October 2025 Common Warrants – director A. DiGiandomenico ($6.81) | $3.92 | $5.9M | 10-K, Mar 31, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| October 2025 Common Warrants – investors ($6.32) | $3.92 | $5.9M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| October 2025 Placement Agent Warrants (Lucid) | $3.92 | $5.9M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| October 2025 Pre-Funded Warrants (2025 Private Placement) | $3.92 | $5.9M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Placement Agent Warrants (June 2024 offering, Craig-Hallum) | $3.92 | $5.9M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Residual legacy warrants (pre-2024 block; likely May 2023 offering warrants) | $3.92 | $5.9M | 10-K, Mar 31, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Series A Warrants (June 2024 registered offering) | $3.92 | $5.9M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Series B Warrants (June 2024 registered offering) | $3.92 | $5.9M | 10-K, Mar 31, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| IPO Representative's Warrants (R.F. Lafferty & Co., Inc.) issued April 4, 2025 | $1.95 | $5.8M | 20-F, Aug 13, 2026Dilution tabAs of Nov 13, 2026 |
CNSPCNS Pharmaceuticals, Inc.$4.15Last price
Series F Common Warrants (May 2025 public offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.1M
WKSPWorksport Ltd.$0.3011Last price
August 2026 Inducement Warrants ($0.60)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.1M
WKSPWorksport Ltd.$0.3011Last price
Extended Legacy Warrants ($40.00, exp. Dec 31, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.1M
WKSPWorksport Ltd.$0.3011Last price
March 2026 Consultant Warrants ($4.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.1M
WKSPWorksport Ltd.$0.3011Last price
March 2026 Consultant Warrants ($5.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.1M
WKSPWorksport Ltd.$0.3011Last price
Regulation A Unit Warrants ($4.50)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.1M
WKSPWorksport Ltd.$0.3011Last price
September 2024 PIPE Warrants ($4.00, exp. 2029)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.1M
PRSOPeraso Inc.$0.2868Last price
June 2023 Placement Agent Warrants (equity-classified 'Common stock warrants')
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.0M
PRSOPeraso Inc.$0.2868Last price
Nant Capital common warrants (October 2026 private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.0M
PRSOPeraso Inc.$0.2868Last price
Nant Capital pre-funded warrants (October 2026 private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.0M
PRSOPeraso Inc.$0.2868Last price
November 2024 placement agent warrants (labelled 'Series C warrants issued' at $1.625)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.0M
PRSOPeraso Inc.$0.2868Last price
Purchase Warrants issued - June 2023 (liability-classified)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.0M
PRSOPeraso Inc.$0.2868Last price
Purchase Warrants issued - November 2022 (liability-classified)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.0M
PRSOPeraso Inc.$0.2868Last price
Representative (underwriter) warrants - February 2024
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.0M
PRSOPeraso Inc.$0.2868Last price
September 2025 placement agent warrants (labelled 'Series E warrants issued' at $1.475)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.0M
PRSOPeraso Inc.$0.2868Last price
Series A warrants (February 2024 public offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.0M
PRSOPeraso Inc.$0.2868Last price
Series D warrants (November 2024 inducement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.0M
PRSOPeraso Inc.$0.2868Last price
Series E warrants (September 2025 inducement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.0M
ACXPAcurx Pharmaceuticals, Inc.$0.9900Last price
April 2026 Pre-Funded Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.0M
ACXPAcurx Pharmaceuticals, Inc.$0.9900Last price
January 2025 Placement Agent Warrants (H.C. Wainwright)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.0M
ACXPAcurx Pharmaceuticals, Inc.$0.9900Last price
July 2022 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.0M
ACXPAcurx Pharmaceuticals, Inc.$0.9900Last price
June 2025 Placement Agent Warrants (H.C. Wainwright)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.0M
ACXPAcurx Pharmaceuticals, Inc.$0.9900Last price
Legacy warrants not itemised (pre-2025 residual)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.0M
ACXPAcurx Pharmaceuticals, Inc.$0.9900Last price
March 2025 Placement Agent Warrants (H.C. Wainwright)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.0M
ACXPAcurx Pharmaceuticals, Inc.$0.9900Last price
Series A Warrants issued to affiliates (July 2022)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.0M
ACXPAcurx Pharmaceuticals, Inc.$0.9900Last price
Series E Warrants (January 2025 private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.0M
ACXPAcurx Pharmaceuticals, Inc.$0.9900Last price
Series F Warrants (March 2025 private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.0M
ACXPAcurx Pharmaceuticals, Inc.$0.9900Last price
Series G-1 Warrants (June 2025 inducement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.0M
ACXPAcurx Pharmaceuticals, Inc.$0.9900Last price
Series G-2 Warrants (June 2025 inducement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.0M
ACXPAcurx Pharmaceuticals, Inc.$0.9900Last price
Series H Warrants (April 2026 private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.0M
GWAVGreenwave Technology Solutions, Inc.$2.01Last price
Warrants at $165.00 exercise price (10-Q warrant table)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.0M
GWAVGreenwave Technology Solutions, Inc.$2.01Last price
Warrants at $320.10 exercise price (10-Q warrant table)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.0M
OXBROxbridge Re Holdings Limited$0.7204Last price
Public warrants (NASDAQ: OXBRW), $7.50, expiring March 26, 2029
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$5.9M
OXBROxbridge Re Holdings Limited$0.7204Last price
Series A Ordinary Share Purchase Warrants (Feb 2025 private placement), $4.25, expiring Feb 24, 2027
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$5.9M
OXBROxbridge Re Holdings Limited$0.7204Last price
Series B Ordinary Share Purchase Warrants (Feb 2025 private placement), $4.25, expiring May 8, 2030
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$5.9M
CNEYCN Energy Group Inc. Class A Ordinary Shares$0.4324Last price
January 2023 pre-funded warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$5.9M
CNEYCN Energy Group Inc. Class A Ordinary Shares$0.4324Last price
January 2023 public offering warrants (Aegis underwritten offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$5.9M
CNEYCN Energy Group Inc. Class A Ordinary Shares$0.4324Last price
New Warrants (December 2024 warrant inducement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$5.9M
NDRAENDRA Life Sciences Inc.$3.92Last price
Advisory Warrants – Arca, immediately exercisable tranche
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$5.9M
NDRAENDRA Life Sciences Inc.$3.92Last price
May 2026 Placement Agent Pre-Funded Warrants (Lucid)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$5.9M
NDRAENDRA Life Sciences Inc.$3.92Last price
May 2026 Pre-Funded Warrants – LHE LNG, exercisable portion
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$5.9M
NDRAENDRA Life Sciences Inc.$3.92Last price
October 2025 Common Warrants – director A. DiGiandomenico ($6.81)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$5.9M
NDRAENDRA Life Sciences Inc.$3.92Last price
October 2025 Common Warrants – investors ($6.32)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$5.9M
NDRAENDRA Life Sciences Inc.$3.92Last price
October 2025 Placement Agent Warrants (Lucid)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$5.9M
NDRAENDRA Life Sciences Inc.$3.92Last price
October 2025 Pre-Funded Warrants (2025 Private Placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$5.9M
NDRAENDRA Life Sciences Inc.$3.92Last price
Placement Agent Warrants (June 2024 offering, Craig-Hallum)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$5.9M
NDRAENDRA Life Sciences Inc.$3.92Last price
Residual legacy warrants (pre-2024 block; likely May 2023 offering warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$5.9M
NDRAENDRA Life Sciences Inc.$3.92Last price
Series A Warrants (June 2024 registered offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$5.9M
NDRAENDRA Life Sciences Inc.$3.92Last price
Series B Warrants (June 2024 registered offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$5.9M
IPO Representative's Warrants (R.F. Lafferty & Co., Inc.) issued April 4, 2025
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$5.8M
Source: SEC filings cited in each company’s dilution snapshot, compiled by Signal8, as of November 17, 2026.
Read from 2,072 dilution snapshots. 4,873 of 5,328 series state an exercise price and 3,364 an expiry date. 198 record when exercise begins; that count grows as companies are re-extracted. 625 series are left off because their figures could not be restated for a stock split. 19 companies and 0 series are held back pending review. Share counts, exercise prices, expiry dates and terms are included in Signal8 Pro. Not investment advice.
About this list
Most of the companies listed are small caps and penny stocks, where warrants are routinely issued with registered direct offerings, PIPEs and underwritten unit deals. When a warrant is exercised the company issues new shares, so the list is a record of shares that do not exist yet but can be issued.
Coverage is limited to the companies Signal8 has a dilution snapshot for. A company that is not listed may still have warrants outstanding, and a figure shown as Not stated was not found in the filings read, which is not a statement that it is zero.
The date a warrant first becomes exercisable is recorded only for companies extracted since Signal8 started reading it. Not recorded yet means the snapshot predates that field, not that the warrant is exercisable. Coverage grows as companies are re-extracted.
Frequently asked questions
- What is a stock warrant?
- A warrant gives its holder the right to buy new shares from the company at a fixed exercise price until an expiry date. When warrants are exercised the company issues new shares, which adds to the share count. Unlike an exchange-listed option, a warrant is issued by the company itself, usually alongside a financing.
- What does in the money mean for a warrant?
- A warrant is in the money when the current share price is above its exercise price, so exercising it costs less than buying the shares on the market. This page compares the last price with the exercise price after restating both for any stock split, and says No recent price when there is no price from the last 7 days.
- Which warrants are expiring soon?
- Each row shows the expiry date stated in the filing, and series that expire within 30 days are marked. A warrant that is not exercised by its expiry date lapses and no shares are issued for it. A row whose stated date has passed says so; the filing record does not show whether that series was exercised before it lapsed.
- What is a warrant exercise price reset or full ratchet?
- Some warrants lower their exercise price if the company later sells shares more cheaply. A full ratchet resets it to the new lower price; a weighted-average adjustment moves it part of the way; some warrants reset on a set date to a price tied to the market. A lower exercise price can also raise the number of shares the warrant covers. The Terms column shows the adjustment the filing describes.
- What is a pre-funded warrant?
- A pre-funded warrant is one where the buyer has already paid almost the whole price up front, leaving a nominal exercise price such as $0.0001 per share. It is in the money by construction, so this page marks it as such and does not rank it by distance from the strike.
- Why are exercise prices split-adjusted?
- Filings state exercise prices and share counts as of their filing date. After a reverse split a warrant covers fewer shares at a higher price. Signal8 restates both onto the current share basis; a series whose basis cannot be resolved is left off the page and counted under the table, rather than shown as filed.
- What is warrant overhang?
- Overhang is the number of shares the warrants can be exercised into, shown here as a percentage of shares outstanding, with both figures on the same split basis. Not measured means one of the two figures is missing.
- Where does the data come from and how often is it updated?
- Each row is read from the SEC filings cited in that company’s Signal8 dilution snapshot, and the source filing link on every row opens the document the figures were taken from. The list is rebuilt from the latest snapshots at least every 30 minutes, and each row shows the date of the snapshot it was read from.
Related
- PIPE tracker: private placements and registered directs
- Pending S-1 filings: offerings not yet effective
- Reverse split calendar
- Recently delisted stocks
- High dilution scanner
- Stock dilution checker
- Warrant overhang: how to count shares not issued yet
- Warrant price resets and ratchets explained
- Warrant inducements explained
- Warrants vs options
- How to read the Signal8 dilution tab
Not investment advice.